new COX-2 inhibitor called Bextra (valdecoxib)
January 2002
You'll see a new COX-2 inhibitor called Bextra (valdecoxib).
It'll be co-marketed by Pharmacia and Pfizer...the same companies that market Celebrex (celecoxib).
Bextra is approved for osteoarthritis...rheumatoid arthritis...and dysmenorrhea. It's NOT approved yet for acute pain...but it probably will be after the company submits additional studies to the FDA.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote